| Gene symbol | CT83 | Synonyms | CXorf61, KK-LC-1, KKLC1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq23 | dbXrefs | |
| Description | cancer/testis antigen 83 | ||||
| GTO ID | GTC2036 |
| Trial ID | NCT03778814 |
| Disease | Lung Non-Small Cell Carcinoma |
| Altered gene | KK-LC-1|Neoantigen |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | KK-LC-1/Neoantigen TCR-T cells |
| HLA | HLA-A*11 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | TCR-T Cells Targeting Cancer Cells for Immunotherapy of Lung Cancer and Other Solid Tumors: Phase I Clinical Trial |
| Year | 2018 |
| Country | China |
| Company sponsor | Second Affiliated Hospital of Guangzhou Medical University |
| Other ID(s) | ZZTCRT-005 |
| Cohort 1 | |||||||||
|
|||||||||